Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K δ

Authors

Keywords

Journal

Volume 361, Issue 3, Pages 429-440

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Online

2017-04-26

DOI

10.1124/jpet.116.237347

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started